Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Rebetol (Ribavirin) Available In Spain for Combination Hepatitis C Therapy COSTA MESA, CA -- May 10, 2000 -- ICN Pharmaceuticals, Inc. a research-based, global pharmaceutical company said today that its licensing partner Schering-Plough Corporation has commenced sales in Spain of Rebetol(R) (ribavirin) Capsules. Rebetol is approved for use in combination with Schering-Plough's interferon alfa-2b injection for the treatment of chronically infected hepatitis C patients. Sales in Spain of Rebetol follow its launch in Germany, Italy and the United Kingdom in 1999. As many as five million people in Western Europe, and about one percent of the population in Spain, are chronically infected with the hepatitis C virus, according to the World Health Organization (Dec. 1999). The infection is the leading cause of liver disease in Western Europe and the most common reason for liver transplant. Schering-Plough has exclusive worldwide rights to market oral ribavirin for hepatitis C under a license from ICN. Ribavirin, discovered and developed by ICN, is a synthetic nucleoside analog with broad-spectrum antiviral activity. Ribavirin is currently marketed by ICN as Virazole(R) for the treatment of RSV and in a variety of other dosage forms for at least one of 10 indications in 44 other countries. In the United States, Schering-Plough markets Rebetron(TM) Combination Therapy containing Rebetol (ribavirin, USP) Capsules and Intron(R) A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C. It also markets the combination therapy in Canada and Argentina. Some four million Americans are infected with the hepatitis C virus, according to the Centers for Disease Control and Prevention (CDC). ICN manufactures, markets and distributes a broad range of prescription and non-prescription pharmaceuticals throughout the world under the ICN brand name. Related Links: Rebetol (ribavirin), ICN Pharmaceuticals, Inc. and Schering-Plough Corporation. E-mail this page to a friend or colleague! To print, use this version